Corrigendum: A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022

Front Cell Infect Microbiol. 2023 Aug 24:13:1264974. doi: 10.3389/fcimb.2023.1264974. eCollection 2023.

Abstract

[This corrects the article DOI: 10.3389/fcimb.2023.1155293.].

Keywords: COVID-19; Omicron variant; SARS-CoV-2; bispecific antibody; single-chain variable fragment.

Publication types

  • Published Erratum